(Q34515196)

2 August 2017

title

Two double-blind placebo-controlled pilot studies of eicosapentaenoic acid in the treatment of schizophrenia (English)

1 reference

2 August 2017

0 references

0 references

M Peet

1

1 reference

2 August 2017

J Brind

2

1 reference

2 August 2017

C N Ramchand

3

1 reference

2 August 2017

S Shah

4

1 reference

2 August 2017

G K Vankar

5

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 April 2001

1 reference

2 August 2017

published in

Schizophrenia Research

1 reference

2 August 2017

volume

49

1 reference

2 August 2017

issue

3

1 reference

2 August 2017

page(s)

243-251

1 reference

The effects of dietary alpha-linolenic acid compared with docosahexaenoic acid on brain, retina, liver, and heart in the guinea pig.

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900083-9

7 January 2021

Phospholipase A2 activity in serum of neuroleptic-naive psychiatric inpatients

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900083-9

7 January 2021

Docosahexanoic acid (22:6, n-3) but not eicosapentaenoic acid (20:5, n-3) can induce neutrophil-mediated injury of cultured endothelial cells: involvement of neutrophil elastase

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900083-9

7 January 2021

Fat consumption and schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900083-9

7 January 2021

Are fish oils beneficial in the prevention and treatment of coronary artery disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900083-9

7 January 2021

The omega-3 fatty acid docosahexaenoate reduces cytokine-induced expression of proatherogenic and proinflammatory proteins in human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900083-9

7 January 2021

alpha-Linolenic acid dietary deficiency alters age-related changes of dopaminergic and serotoninergic neurotransmission in the rat frontal cortex.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900083-9

7 January 2021

Schizophrenia and rheumatoid arthritis: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900083-9

7 January 2021

Purification and characterisation of phospholipase A2 from human epidermis

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900083-9

7 January 2021

Increased plasma phospholipase-A2 activity in schizophrenic patients: reduction after neuroleptic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900083-9

7 January 2021

Increased platelet phospholipase A2 activity in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900083-9

7 January 2021

Opposite regulation of prostaglandin H synthase isoforms by eicosapentaenoic and docosahexaenoic acids

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900083-9

7 January 2021

A red cell membrane abnormality in a subgroup of schizophrenic patients: evidence for two diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900083-9

7 January 2021

Characteristics of phospholipid methylation in human erythrocyte ghosts: relationship(s) to the psychoses and affective disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900083-9

7 January 2021

Fatty acid levels in the brains of schizophrenics and normal controls.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900083-9

7 January 2021

The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900083-9

7 January 2021

Equal antithrombotic and triglyceride-lowering effectiveness of eicosapentaenoic acid-rich and docosahexaenoic acid-rich fish oil supplements

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900083-9

7 January 2021

The positive and negative syndrome scale (PANSS) for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900083-9

7 January 2021

Erythrocyte membrane phospholipids in psychotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900083-9

7 January 2021

A role for phospholipid polyunsaturation in modulating membrane protein function

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900083-9

7 January 2021

The Role of Membrane Lipids in Receptor Mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900083-9

7 January 2021

Plasma membrane phospholipid and cholesterol distribution of skin fibroblasts from drug-naive patients at the onset of psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900083-9

7 January 2021

Fatty acids in plasma and red cell membranes in normal humans

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900083-9

7 January 2021

Changes in dietary fatty acids alter phospholipid fatty acid composition in selected regions of rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900083-9

7 January 2021

Identification of skin as a major site of prostaglandin D2 release following oral administration of niacin in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900083-9

7 January 2021

Elevated PLA2 activity in schizophrenics and other psychiatric patients

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900083-9

7 January 2021

Eicosapentaenoic acid inhibits prostaglandin D2 generation by inhibiting cyclo-oxygenase-2 in cultured human mast cells

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900083-9

7 January 2021

Eicosapentaenoic acid enhances intracellular free calcium in cultured human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900083-9

7 January 2021

Increased platelet membrane lysophosphatidylcholine in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900083-9

7 January 2021

Depleted red cell membrane essential fatty acids in drug-treated schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900083-9

7 January 2021

Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics. A pilot study of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance spectroscopy.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900083-9

7 January 2021

Sustained Remission of Positive and Negative Symptoms of Schizophrenia Following Treatment With Eicosapentaenoic Acid

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900083-9

7 January 2021

Increased phospholipid breakdown in schizophrenia. Evidence for the involvement of a calcium-independent phospholipase A2.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900083-9

7 January 2021

Membrane phospholipid metabolism and schizophrenia: an in vivo 31P-MR spectroscopy study

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900083-9

7 January 2021

Role of fatty acids in signal transduction: modulators and messengers

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900083-9

7 January 2021

Mechanism of lipid mobilization associated with cancer cachexia: interaction between the polyunsaturated fatty acid, eicosapentaenoic acid, and inhibitory guanine nucleotide-regulatory protein

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900083-9

7 January 2021

Effect of neuroleptics on phospholipase A2 activity in the brain of rats

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900083-9

7 January 2021

Treatment of nonpsychotic relatives of patients with schizophrenia: four case studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900083-9

7 January 2021

A controlled trial of prostaglandin E1 precursor in chronic neuroleptic resistant schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900083-9

7 January 2021

A double-blind trial of essential fatty acid supplementation in patients with tardive dyskinesia.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900083-9

7 January 2021

The new antipsychotics, and their potential for early intervention in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900083-9

7 January 2021

Niacin skin flush in schizophrenia: a preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900083-9

7 January 2021

Retinal function as a marker for cell membrane omega-3 fatty acid depletion in schizophrenia: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900083-9

7 January 2021

Eicosapentaenoic acid, but not docosahexaenoic acid, increases mitochondrial fatty acid oxidation and upregulates 2,4-dienoyl-CoA reductase gene expression in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900083-9

7 January 2021

Essential fatty acid supplementation in tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900083-9

7 January 2021

Red blood cell membrane dynamics in schizophrenia. II. Fatty acid composition

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900083-9

7 January 2021

Red blood cell membrane dynamics in schizophrenia. III. Correlation of fatty acid abnormalities with clinical measures

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900083-9

7 January 2021

Is pre-psychotic intervention realistic in schizophrenia and related disorders?

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900083-9

7 January 2021

10.1016/S0920-9964(00)00083-9

Identifiers

DOI

1 reference

release_74dmaxs2hbbv3jfbbshto4ml2i

2 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/74dmaxs2hbbv3jfbbshto4ml2i

24 November 2022

mapped directly with Wikidata item

1 reference